French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). (Q46867061)
Jump to navigation
Jump to search
scientific article published on 10 January 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). |
scientific article published on 10 January 2006 |
Statements
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC) (English)
René-Jean Bensadoun
Karen Bénézery
Olivier Dassonville
Nicolas Magné
Gilles Poissonnet
Alain Ramaïoli
Sylvain Bourdin
Jacques Tortochaux
Frédéric Peyrade
Pierre-Yves Marcy
Emmanuel Chamorey
Jacques Vallicioni
Hang Seng
Claude Alzieu
Bernard Géry
Maurice Schneider
José Santini
François Demard
Gilles Calais
10 January 2006